OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers

Slides:



Advertisements
Similar presentations
Modify ABO Subtyping References for Consistency Operations and Safety Committee November 12-13, 2014.
Advertisements

Policy Oversight Committee (POC) Report OPTN/UNOS Board of Directors Yolanda Becker, MD, Chair Sue Dunn, RN, BSN, MBA, Vice Chair November 12-13, 2014.
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
Definition of Transplant Policy Oversight Committee (POC) Fall 2014.
Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda.
Proposal to Collect Extracorporeal Membrane Oxygenation (ECMO) Data When Removing Lung Candidates from Waitlist Thoracic Organ Transplantation Committee.
Guidance to Organ Procurement Organizations for Allocation of Heart-Lung Blocks (Resolution 12) OPTN/UNOS Thoracic Organ Transplantation Committee Dr.
Recognizing Seasonal and Geographically Endemic Infections in Organ Donors: Considerations during Living Donor Evaluation (Resolution 16) Ad Hoc Disease.
Proposal to Require the Collection of Serum Lipase for all Pancreas Donors (Resolution 5) Pancreas Transplantation Committee Jonathan Fridell, MD, Chair.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Modifications to Approved Lung Allocation Policy (Resolution 25) OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers.
Proposal to Delay the HCC Exception Score Assignment (Resolution 9) Liver and Intestine Committee David Mulligan, Chair November 12 and 13, 2014.
Proposed Membership and Personnel Requirements for Intestine Transplant Programs Liver and Intestinal Organ Transplantation Committee Spring 2015.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
Planning and Community Development Department Housing Element City Council February 03, 2014.
Proposal for Adolescent Classification Exception for Pediatric Lung Candidates Thoracic Organ Transplantation Committee Spring 2014.
Geographically Isolated Transplant Program Applicants (Resolution 10) Membership & Professional Standards Committee (MPSC) Jonathan Chen, MD, Chair November.
Thoracic Organ Transplantation Committee Fall 2012 Public Comment Cycle.
1 Addressing the Term “Foreign Equivalent” in OPTN/UNOS Bylaws Membership and Professional Standards Committee Fall 2015.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
OPTN Proposal to Revise the Lung Allocation Score (LAS) System and Salient Activities of the Thoracic Organ Transplantation Committee.
Clarify Policy Language and Process for Individual Waiting Time Transfer Patient Affairs Committee Spring 2015.
OPTN/UNOS HISTOCOMPATIBILITY COMMITTEE REPORT TO THE BOARD OF DIRECTORS JUNE 25-26, 2012 RICHMOND, VA Nancy L. Reinsmoen, PhD., Chair.
Proposal to Notify Patients Having an Extended Inactive Status Transplant Coordinators Committee Spring 2014.
Requiring Transplant Programs to Report in UNet℠ a Change in Criterion or Status within 24 Hours of that Change, and Other Edits Sponsored by the Thoracic.
Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Membership & Professional Standards Committee (MPSC)
Guidance for VCA Deceased Donor Authorization (Resolution 7)
Updating Primary Kidney Transplant Physician Requirements
Rewrite of Article II: Board of Directors
Pediatric Transplantation Committee
Minority Affairs Committee
Revisions to Pediatric Emergency Membership Exception
Manipulation of the Waitlist Priority of the Organ Allocation System through the Escalation of Medical Therapies Ethics Committee.
Thoracic Organ Transplantation Committee
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
Thoracic Organ Transplantation Committee
Organ Procurement Organization Committee Report
Thoracic Organ Transplantation Committee Spring 2015
Thoracic Organ Transplantation Committee Spring 2014
Histocompatibility Laboratory Bylaws and Policies Guidance Document
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Mark S. Orloff, MD Regional Councillor
Liver and Intestinal Organ Transplantation Committee Update Report
Proposal to Require the Reporting of Aborted Living Donor Organ Recovery Procedures (Resolution 19) Living Donor Committee Mary Amanda Dew, PhD.
OPTN/UNOS Thoracic Organ Transplantation Committee
Pancreas Program Functional Inactivity
Thoracic Organ Transplantation Committee Spring 2019
Modify HOPE Act Variance to Include Other Organs
Action Items from the Kidney Transplantation Committee
Membership and Professional Standards Committee
Living Donor Committee
Thoracic Organ Transplantation Committee
Executive Committee Update
Vascularized Composite Allograft (VCA) Transplantation Committee
Thoracic Organ Transplantation Committee
Proposal to Notify Patients Having an Extended Inactive Status
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Membership & Professional Standards Committee
Thoracic Organ Transplantation Committee
Policy Rewrite Parking Lot Quick Fixes
Membership & Professional Standards Committee Fall 2014
Thoracic Organ Transplantation Committee
Imminent and Eligible Death Data Definitions Change Effective Date
Thoracic Organ Transplantation Committee
Region 8 Meeting Harvey Solomon, MD
Fall 2012 Public Comment Cycle
OPTN/UNOS Histocompatibility Committee
Thoracic Organ Transplantation Committee
Presentation transcript:

OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers Clarification to Policy 10.1.G: Reporting Additional Data for Candidates with an LAS of 50 or Higher (Resolution 26) OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers

Background Policy 10.1.G: Reporting Additional Data for Candidates with an LAS of 50 or Higher effective February 1, 2012 Every 14 days, for candidates with LAS of 50 or higher, transplant programs must report: Assisted Ventilation Supplemental Oxygen PCO2 *

Policy 10.1.G cannot be monitored as written The Problem Policy 10.1.G cannot be monitored as written

#6: Promote the Efficient Management of the OPTN Strategic Plan #6: Promote the Efficient Management of the OPTN Clearly communicate with members

Work with DEQ to: Clarify LAS variables that must be reported Goal of the Proposal Work with DEQ to: Clarify LAS variables that must be reported Clarify timing of reporting requirements

How the Proposal Will Achieve Its Goal Changes to policy language Current policy: “any observed changes” Proposed policy: removes reference to “any observed changes” Monitoring: Candidate’s data must be assessed and reported every 14 days even if no changes Current policy: “three key variables” Proposed policy: removes reference to “three” Monitoring: DEQ will review all fields related to supplemental oxygen (frequency and amount), and PCO2 (venous, capillary, or arterial)

Overall Project Impact Product Policy Modification Target Population Impact: Lung transplant candidates with an LAS of 50 or higher Total IT Implementation Hours 0/10,680 Total Overall Implementation Hours 20/17,885

Resolution 26 (page 111) RESOLVED, the modifications to Policy 10.1.G (Reporting Additional Data for Candidates with an LAS of 50 or Higher), as set forth in Exhibit C, are hereby approved, effective February 1, 2015.

Proposed Policy Within 14 days of the date a candidate’s LAS becomes 50 or higher, A the candidate’s transplant program must assess and report data for three key variables to the OPTN Contractor the following variables no more than 14 days after a candidate’s LAS becomes 50 or higher:   Assisted ventilation Supplemental oxygen Current PCO2 The transplant program is only required to report an updated PCO2 value if the test was performed within those 14 days. While the candidate’s LAS score remains 50 or higher, the transplant program must continue to assess and report any observed changes in the three clinical key variables assisted ventilation and supplemental oxygen every 14 days. The transplant program is only required to report updated PCO2 data if the assessment was performed during the previous 14 day interval. The transplant program must maintain documentation of each assessment in the candidate’s medical chart.